• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者的神经免疫相互作用:基于 P 物质血清水平的疾病活动和临床行为。

Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels.

机构信息

Department of Surgery, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy.

出版信息

J Crohns Colitis. 2012 Jun;6(5):563-70. doi: 10.1016/j.crohns.2011.11.004. Epub 2011 Dec 13.

DOI:10.1016/j.crohns.2011.11.004
PMID:22398048
Abstract

BACKGROUND AND AIM

The neuropeptide Substance P, plays a key role in modulating neuroimmune interactions in patients with inflammatory bowel diseases. We analyzed Substance P serum levels in patients with ulcerative colitis and Crohn's disease, to detail the involvement of the neuropeptide in the pathophysiology of these disorders.

METHODS

Serum samples were collected from 61 patients with ulcerative colitis (24 with active and 37 with inactive disease), 66 patients with Crohn's disease (29 with active and 37 with inactive disease) and 45 healthy subjects, enrolled into the study. Neuropetide serum levels were measured by means of an ELISA/EIA. Associations with disease activity and patients clinical features were also taken into account.

RESULTS

Compared to controls, Substance P serum levels were significantly increased in both patients with ulcerative colitis and Crohn's disease, (p<0.001). In patients with ulcerative colitis, levels paralleled disease activity (p=0.014), and the amount of the neuropeptide was considerably decreased during clinical and endoscopic remission of the disease, (p=0.025). Conversely, median Substance P levels did not differ between patients with active and inactive Crohn's disease. However, levels of the neuropeptide were more often elevated in patients with inactive and stricturing/fistulizing Crohn's disease, (p=0.002).

CONCLUSIONS

Data underline that Substance P might exerts important immunomodulatory functions in inflammatory bowel disease. This study suggests a potential role for Substance P serum levels in monitoring intestinal inflammation in patients with inflammatory bowel disease.

摘要

背景与目的

神经肽 P 物质在调节炎症性肠病患者的神经免疫相互作用中起着关键作用。我们分析了溃疡性结肠炎和克罗恩病患者的 P 物质血清水平,以详细阐明该神经肽在这些疾病病理生理学中的作用。

方法

从溃疡性结肠炎患者(活动期 24 例,缓解期 37 例)、克罗恩病患者(活动期 29 例,缓解期 37 例)和 45 名健康对照者中采集血清样本。采用 ELISA/EIA 法测定神经肽血清水平,并考虑疾病活动度和患者临床特征的相关性。

结果

与对照组相比,溃疡性结肠炎和克罗恩病患者的 P 物质血清水平均显著升高(p<0.001)。在溃疡性结肠炎患者中,水平与疾病活动度相关(p=0.014),并且在疾病的临床和内镜缓解期间,神经肽的量明显减少(p=0.025)。相反,活动期和缓解期克罗恩病患者的 P 物质水平中位数无差异。然而,在缓解期和狭窄/瘘管形成克罗恩病患者中,神经肽水平升高更为常见(p=0.002)。

结论

数据表明 P 物质可能在炎症性肠病中发挥重要的免疫调节功能。本研究提示 P 物质血清水平在监测炎症性肠病患者肠道炎症方面具有潜在作用。

相似文献

1
Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels.炎症性肠病患者的神经免疫相互作用:基于 P 物质血清水平的疾病活动和临床行为。
J Crohns Colitis. 2012 Jun;6(5):563-70. doi: 10.1016/j.crohns.2011.11.004. Epub 2011 Dec 13.
2
Serum prohepcidin levels in chronic inflammatory bowel diseases.慢性炎症性肠病患者血清铁调素水平。
J Crohns Colitis. 2010 Dec;4(6):649-53. doi: 10.1016/j.crohns.2010.07.010.
3
Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.中性粒细胞明胶酶相关脂质运载蛋白作为克罗恩病和溃疡性结肠炎疾病活动的指标。
J Clin Gastroenterol. 2013 Mar;47(3):246-51. doi: 10.1097/MCG.0b013e3182582cdb.
4
Increased serum levels of YKL-40 in patients with inflammatory bowel disease.炎症性肠病患者血清中YKL-40水平升高。
Int J Colorectal Dis. 2003 May;18(3):254-9. doi: 10.1007/s00384-002-0446-z. Epub 2002 Nov 30.
5
Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.炎症性肠病中的血清ST2:一种疾病活动的潜在生物标志物。
J Investig Med. 2016 Jun;64(5):1016-24. doi: 10.1136/jim-2016-000062. Epub 2016 Mar 21.
6
Mean platelet volume: a useful marker of inflammatory bowel disease activity.平均血小板体积:炎症性肠病活动的一个有用标志物。
Am J Gastroenterol. 2001 Mar;96(3):776-81. doi: 10.1111/j.1572-0241.2001.03621.x.
7
Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.炎症性肠病患者血清生物标志物与内镜活动度的相关性
Gastroenterol Hepatol. 2016 Oct;39(8):508-15. doi: 10.1016/j.gastrohep.2016.01.015. Epub 2016 Mar 25.
8
Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases.炎症性肠病中膜金属肽酶基因的遗传变异。
Dig Liver Dis. 2013 Dec;45(12):1003-10. doi: 10.1016/j.dld.2013.05.010. Epub 2013 Jul 1.
9
Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.克罗恩病患儿血清白细胞介素-6升高,但血清可溶性白细胞介素-2受体未升高。
J Pediatr Gastroenterol Nutr. 1996 Aug;23(2):164-71. doi: 10.1097/00005176-199608000-00012.
10
FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.粪便钙卫蛋白:巴西胃肠道症状患者病因诊断的水平
Arq Gastroenterol. 2015 Jan-Mar;52(1):50-4. doi: 10.1590/S0004-28032015000100011.

引用本文的文献

1
Estrogen deprivation and estrogen receptor α antagonism decrease DSS colitis in female mice.雌激素剥夺和雌激素受体 α 拮抗剂可减少雌性小鼠的 DSS 结肠炎。
Pharmacol Res Perspect. 2024 Aug;12(4):e1234. doi: 10.1002/prp2.1234.
2
Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review.纤维狭窄型克罗恩病的预测和诊断生物标志物:系统评价。
Clin Gastroenterol Hepatol. 2022 Apr;20(4):817-846.e10. doi: 10.1016/j.cgh.2021.05.054. Epub 2021 Jun 2.
3
Role of perivascular nerve and sensory neurotransmitter dysfunction in inflammatory bowel disease.
血管周围神经和感觉神经递质功能障碍在炎症性肠病中的作用。
Am J Physiol Heart Circ Physiol. 2021 May 1;320(5):H1887-H1902. doi: 10.1152/ajpheart.00037.2021. Epub 2021 Mar 12.
4
Intestinal changes associated with fluoride exposure in rats: Integrative morphological, proteomic and microbiome analyses.肠道变化与大鼠氟暴露的关系:综合形态学、蛋白质组学和微生物组学分析。
Chemosphere. 2021 Jun;273:129607. doi: 10.1016/j.chemosphere.2021.129607. Epub 2021 Jan 11.
5
Role of Substance P in the Pathophysiology of Inflammatory Bowel Disease and Its Correlation With the Degree of Inflammation.P物质在炎症性肠病病理生理学中的作用及其与炎症程度的相关性。
Cureus. 2020 Oct 18;12(10):e11027. doi: 10.7759/cureus.11027.
6
Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception.急性肠套叠婴儿血清P物质和血管活性肠肽水平
J Int Med Res. 2019 Jun;47(6):2446-2451. doi: 10.1177/0300060519844401. Epub 2019 Apr 21.
7
Communication Between Enteric Neurons, Glia, and Nociceptors Underlies the Effects of Tachykinins on Neuroinflammation.肠神经元、神经胶质细胞和伤害感受器之间的通讯是速激肽对神经炎症影响的基础。
Cell Mol Gastroenterol Hepatol. 2018 May 29;6(3):321-344. doi: 10.1016/j.jcmgh.2018.05.009. eCollection 2018.
8
Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.血清 P 物质:类风湿关节炎疾病活动和亚临床炎症的指标。
Clin Rheumatol. 2018 Apr;37(4):901-908. doi: 10.1007/s10067-017-3929-6. Epub 2017 Dec 18.
9
Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.溃疡性结肠炎中,中性肽链内切酶显著缺失,同时伴有神经肽水平降低和C反应蛋白升高。
PLoS One. 2017 Dec 12;12(12):e0189526. doi: 10.1371/journal.pone.0189526. eCollection 2017.
10
Biomarkers of inflammatory bowel disease.炎症性肠病的生物标志物。
Dis Markers. 2014;2014:710915. doi: 10.1155/2014/710915. Epub 2014 May 19.